A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence
- 1 December 2011
- journal article
- research article
- Published by Elsevier BV in Drug and Alcohol Dependence
- Vol. 119 (1-2), e23-e29
- https://doi.org/10.1016/j.drugalcdep.2011.05.019
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Long-Acting Injectable Versus Oral Naltrexone Maintenance Therapy With Psychosocial Intervention for Heroin DependenceBritish Journal of Psychology, 2010
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependenceEmergencias, 2009
- Self‐administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfallsAddiction Biology, 2008
- Glutamatergic substrates of drug addiction and alcoholismBiochemical Pharmacology, 2008
- Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta‐analytical reviewAddiction, 2006
- Reinstatement of Morphine-Conditioned Reward is Blocked by MemantineNeuropsychopharmacology, 2005
- Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawalBehavioural Brain Research, 2003
- Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in miceBehavioural Pharmacology, 2003
- Behavioral naltrexone therapy: An integrated treatment for opiate dependenceJournal of Substance Abuse Treatment, 2002
- Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studiesNeuroscience & Biobehavioral Reviews, 1997